Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

BUY
$0.5 - $0.73 $105,564 - $154,123
211,128 Added 30.21%
909,931 $482,000
Q4 2023

Jan 24, 2024

SELL
$0.48 - $0.7 $95,664 - $139,510
-199,301 Reduced 22.19%
698,803 $398,000
Q3 2023

Oct 26, 2023

SELL
$0.5 - $1.05 $34,983 - $73,465
-69,967 Reduced 7.23%
898,104 $538,000
Q2 2023

Aug 10, 2023

BUY
$0.55 - $0.89 $10,324 - $16,707
18,772 Added 1.98%
968,071 $735,000
Q1 2023

May 04, 2023

SELL
$0.68 - $1.25 $16,587 - $30,491
-24,393 Reduced 2.51%
949,299 $674,000
Q4 2022

Feb 09, 2023

BUY
$0.96 - $1.34 $934,744 - $1.3 Million
973,692 New
973,692 $1 Million
Q3 2020

Nov 12, 2020

SELL
$0.36 - $0.53 $96,548 - $142,140
-268,189 Closed
0 $0
Q2 2020

Aug 11, 2020

BUY
$0.39 - $0.69 $31,687 - $56,061
81,249 Added 43.46%
268,189 $105,000
Q1 2020

May 12, 2020

BUY
$0.56 - $1.62 $6,522 - $18,869
11,648 Added 6.64%
186,940 $118,000
Q4 2019

Feb 12, 2020

BUY
$0.83 - $1.3 $33,930 - $53,144
40,880 Added 30.41%
175,292 $161,000
Q3 2019

Nov 12, 2019

BUY
$0.97 - $1.94 $33,285 - $66,571
34,315 Added 34.28%
134,412 $133,000
Q2 2019

Aug 13, 2019

BUY
$1.81 - $2.45 $25,416 - $34,402
14,042 Added 16.32%
100,097 $204,000
Q1 2019

May 13, 2019

SELL
$2.3 - $3.27 $2,306 - $3,279
-1,003 Reduced 1.15%
86,055 $211,000
Q4 2018

Feb 11, 2019

SELL
$2.49 - $4.54 $33,873 - $61,762
-13,604 Reduced 13.51%
87,058 $225,000
Q3 2018

Nov 13, 2018

BUY
$3.4 - $4.84 $342,250 - $487,204
100,662 New
100,662 $480,000

Others Institutions Holding SENS

About Senseonics Holdings, Inc.


  • Ticker SENS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 465,447,008
  • Market Cap $517M
  • Description
  • Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...
More about SENS
Track This Portfolio

Track Mirae Asset Global Investments Co., Ltd. Portfolio

Follow Mirae Asset Global Investments Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.